Maipl Therapeutics, Inc.
Maipl Therapeutics is developing first-in-class medicines to treat endometriosis and other diseases.
Maipl Therapeutics, Inc. operates in biotechnology, pharmaceutical based in Greater New York Area, East Coast, Northeastern US, founded in 2023.
As a business in biotechnology, pharmaceutical, Maipl Therapeutics, Inc. is listed here with the public details available about it.
Its base of operations is Greater New York Area, East Coast, Northeastern US.
Its current recorded stage is Pre_Seed.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $135K in funding.
| Sector | Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2023 |
| Employees | c_00001_00010 |
| Stage | pre_seed |
| Total funding | $135,000 |
Website: www.maipltx.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account